Acadia Pharmaceuticals | ACAD - DŁUG





DŁUG Zmiana Data
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.2B 2.76B 2026-06
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 9.42M 216K 2026-06
Cytokinetics USD 1.29B 4.48M 2026-03
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 54.91B 11.54B 2026-06
Incyte USD 38.27M 1.16M 2026-06
J&J USD 49.04B 5.95B 2026-06
Moderna USD 1.3B 7M 2026-03
Neurocrine Biosciences USD 401.8M 4.4M 2026-06
Pfizer USD 63.19B 536M 2026-06
Prothena USD 6.99M 663K 2026-06
PTC Therapeutics USD 2.84B 2.15B 2026-09
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06